Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, May 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 221 articles:
HTML format


 

Single Articles

  1. LAN K, Zhao Y, Fan Y, Ma B, et al
    Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/beta-Catenin Signaling Pathway.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  2. JIANG C, Yang P, Lei J, Li J, et al
    The Application of Iodine Quantitative Information Obtained by Dual-Source Dual-Energy Computed Tomography on Chemoradiotherapy Effect Monitoring for Cervical Cancer: A Preliminary Study.
    J Comput Assist Tomogr. 2017 Apr 26. doi: 10.1097/RCT.0000000000000603.
    Abstract    

    Abstract available


  3. NewsCAP: The racial disparity in cervical cancer mortality is much greater than previously calculated.
    Am J Nurs. 2017;117:14.
    Abstract    



  4. DU G, Cao D, Meng L
    miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
    Mol Med Rep. 2017 Mar 16. doi: 10.3892/mmr.2017.6340.
    Abstract    

    Abstract available

  5. YANG F, Gao B, Li R, Li W, et al
    Expression levels of resistant genes affect cervical cancer prognosis.
    Mol Med Rep. 2017 Mar 15. doi: 10.3892/mmr.2017.6328.
    Abstract    

    Abstract available

  6. VAN DE SCHOOT AJAJ, de Boer P, Visser J, Stalpers LJA, et al
    Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy.
    Acta Oncol. 2017;56:667-674.
    Abstract    

    Abstract available

  7. SABOUR S
    Prediction of rehabilitation needs after treatment of cervical cancer: a methodological mistake.
    Support Care Cancer. 2017 Apr 26. doi: 10.1007/s00520-017-3711.
    Abstract    



  8. CHENG KY, Hao M
    Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-beta1 (TGF-beta1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Med Sci Monit. 2017;23:2017-2028.
    Abstract    

    Abstract available

  9. LIU J, Liu J, Li SZ, Zheng YA, et al
    [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2016;37:475-481.
    Abstract    

    Abstract available

  10. REISENAUER C, Wallwiener D, Brucker SY, Kraemer B, et al
    Pelvic organ prolapse stage IV and cervical cancer FIGO IIa.
    Arch Gynecol Obstet. 2017 Apr 25. doi: 10.1007/s00404-017-4377.
    Abstract    



  11. MBOUMBA BOUASSA RS, Prazuck T, Lethu T, Jenabian MA, et al
    Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
    Expert Rev Anti Infect Ther. 2017 Apr 25. doi: 10.1080/14787210.2017.1322902.
    Abstract    

    Abstract available

  12. ZHANG T, Wang T, Cai P
    Sclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells.
    Mol Med Rep. 2017 Apr 13. doi: 10.3892/mmr.2017.6480.
    Abstract    

    Abstract available

  13. OH BK, Keo P, Bae J, Ko JH, et al
    Variable TERRA abundance and stability in cervical cancer cells.
    Int J Mol Med. 2017 Apr 20. doi: 10.3892/ijmm.2017.2956.
    Abstract    

    Abstract available

  14. WAMBURU K, Busakhala N, Owuor K, Nyagero J, et al
    Association between stage at diagnosis and knowledge on cervical cancer among patients in a Kenyan tertiary hospital: a cross-sectional study.
    Pan Afr Med J. 2016;25.
    Abstract    

    Abstract available

  15. WANG C, Zhou B, Liu M, Liu Y, et al
    miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.
    Oncol Res. 2017;25:463-470.
    Abstract    

    Abstract available

  16. MAPANGA W, Elhakeem A, Feresu SA, Maseko F, et al
    Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol.
    Syst Rev. 2017;6:91.
    Abstract    

    Abstract available

  17. SUN Q, Liang Y, Zhang T, Wang K, et al
    ER-alpha36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells.
    Biochem Biophys Res Commun. 2017 Apr 20. pii: S0006-291X(17)30781.
    Abstract    

    Abstract available

  18. JAIN V, Ratre YK, Amle D, Mishra PK, et al
    Polymorphism of CYP1A1 gene variants rs4646903 and rs1048943 relation to the incidence of cervical cancer in Chhattisgarh.
    Environ Toxicol Pharmacol. 2017;52:188-192.
    Abstract    

    Abstract available

  19. GHANOUNI A, Renzi C, Waller J
    A cross-sectional survey assessing factors associated with reading cancer screening information: previous screening behaviour, demographics and decision-making style.
    BMC Public Health. 2017;17:327.
    Abstract    

    Abstract available

  20. JODDA A, Urbanski B, Piotrowski T, Malicki J, et al
    Relations between doses cumulated in bone marrow and dose delivery techniques during radiation therapy of cervical and endometrial cancer.
    Phys Med. 2017;36:54-59.
    Abstract    

    Abstract available

  21. KASHYAP L, Gandhi AK, Pandey R, Sharma DN, et al
    Locally advanced carcinoma of the cervix associated with pelvic kidney treated with intensity-modulated radiotherapy: Overcoming a therapeutic challenge.
    J Obstet Gynaecol Res. 2017;43:238-242.
    Abstract    

    Abstract available

  22. HAZAWA M, Lin DC, Handral H, Xu L, et al
    ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
    Oncogene. 2017;36:2243-2254.
    Abstract    

    Abstract available

  23. SLABA S, Zaarour Y, Smayra T
    Percutaneous Transvesical Retrograde Ureteral Stent Insertion for Neoplastic Stricture.
    Cardiovasc Intervent Radiol. 2017;40:144-146.
    Abstract    



  24. WONG S, Hong W, Hui P, Buza N, et al
    Comprehensive Analysis of PAX8 Expression in Epithelial Malignancies of the Uterine Cervix.
    Int J Gynecol Pathol. 2017;36:101-106.
    Abstract    

    Abstract available

  25. HAGIHARA M, Yamagishi Y, Izumi K, Miyazaki N, et al
    Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
    J Infect Chemother. 2016;22:559-62.
    Abstract    

    Abstract available

  26. SANGOI AR, Kshirsagar M, Horvai AE, Roma AA, et al
    SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Int J Gynecol Pathol. 2017;36:140-145.
    Abstract    

    Abstract available

  27. GOMEZ-GOMEZ Y, Organista-Nava J, Ocadiz-Delgado R, Garcia-Villa E, et al
    The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17beta-estradiol.
    Int J Oncol. 2016;49:549-58.
    Abstract    

    Abstract available

  28. ALVAREZ-ALTAMIRANO K, Mendoza-Hernandez AN, Carcoba-Tenorio C, Garcia-Garcia JA, et al
    [In Process Citation].
    Nutr Hosp. 2016;33:125.
    Abstract    

    Abstract available

  29. SU X, Xu W, Guan R, Wang Y, et al
    Adjuvant effect of docetaxel on HPV16 L2E6E7 fusion protein vaccine in a mouse model.
    Int Immunopharmacol. 2016;38:16-25.
    Abstract    

    Abstract available

  30. GULIA A, Patel FD, Santam C, Bhavana R, et al
    Clinical significance of geographic miss when using conventional four field radiotherapy technique in treatment of locally advanced carcinoma cervix.
    Indian J Cancer. 2016;53:80-5.
    Abstract    

    Abstract available

  31. AFROZ F, Rasool MT, Nasreen S, Lone MM, et al
    Cancer cervix: An uncommon malignancy in Kashmir, India.
    Indian J Cancer. 2016;53:77-9.
    Abstract    

    Abstract available

  32. KINGNATE C, Tangjitgamol S, Khunnarong J, Manusirivithaya S, et al
    Abnormal uterine cervical cytology in a large tertiary hospital in Bangkok metropolis: Prevalence, management, and outcomes.
    Indian J Cancer. 2016;53:67-73.
    Abstract    

    Abstract available

  33. SRIKANTH S
    Spectrum of cervical lesions observed in 500 cases: Carcinoma cervix the leading cause of death in females.
    Indian J Cancer. 2016;53:61-2.
    Abstract    

    Abstract available

  34. JOSEPH N, Nelliyanil M, Supriya K, Babu Y, et al
    Association between occupational history of exposure to tobacco dust and risk of carcinoma cervix: A case-control study.
    Indian J Cancer. 2016;53:44-9.
    Abstract    

    Abstract available

  35. PENG K, Jiang LY, Teng SW, Wang PH, et al
    Degenerative leiomyoma of the cervix: Atypical clinical presentation and an unusual finding.
    Taiwan J Obstet Gynecol. 2016;55:293-5.
    Abstract    



  36. GANESAN R, Hirschowitz L, Dawson P, Askew S, et al
    Neuroendocrine Carcinoma of the Cervix: Review of a Series of Cases and Correlation With Outcome.
    Int J Surg Pathol. 2016;24:490-6.
    Abstract    

    Abstract available

  37. TUNG WC, Lu M, Granner M, Sohn J, et al
    Assessing Perceived Benefits/Barriers and Self-efficacy for Cervical Cancer Screening among Korean American Women.
    Health Care Women Int. 2017 May 4:0. doi: 10.1080/07399332.2017.1326495.
    Abstract    

    Abstract available

  38. ROSSETTI D, Vitale SG, Tropea A, Biondi A, et al
    New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer.
    Updates Surg. 2017 May 2. doi: 10.1007/s13304-017-0456.
    Abstract    

    Abstract available

  39. DJAVID GE, Bigdeli B, Goliaei B, Nikoofar A, et al
    Photobiomodulation leads to enhanced radiosensitivity through induction of apoptosis and autophagy in human cervical cancer cells.
    J Biophotonics. 2017 May 2. doi: 10.1002/jbio.201700004.
    Abstract    

    Abstract available

  40. OBRZUT B, Semczuk A, Narog M, Obrzut M, et al
    Prognostic Parameters for Patients with Cervical Cancer FIGO Stages IA2-IIB: A Long-Term Follow-Up.
    Oncology. 2017 May 3. doi: 10.1159/000471766.
    Abstract    

    Abstract available

  41. SAADI J, Minig L, Noll F, Saraniti G, et al
    Four Surgical Approaches to Cervical Excision During Laparoscopic Radical Trachelectomy for Early Cervical Cancer.
    J Minim Invasive Gynecol. 2017 Apr 28. pii: S1553-4650(17)30266.
    Abstract    

    Abstract available

  42. ANDREASSEN T, Weiderpass E, Nicula F, Suteu O, et al
    Controversies about cervical cancer screening: A qualitative study of Roma women's (non)participation in cervical cancer screening in Romania.
    Soc Sci Med. 2017;183:48-55.
    Abstract    

    Abstract available

  43. SEN S, Mandal P, Bhattacharya A, Kundu S, et al
    Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
    Tumour Biol. 2017;39:1010428317699799.
    Abstract    

    Abstract available

  44. BECKER AS, Perucho JA, Wurnig MC, Boss A, et al
    Assessment of Cervical Cancer with a Parameter-Free Intravoxel Incoherent Motion Imaging Algorithm.
    Korean J Radiol. 2017;18:510-518.
    Abstract    

    Abstract available

  45. GAMELON-BENICHOU C, Oldrini S, Charra-Brunaud C, Vogin G, et al
    [Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].
    Cancer Radiother. 2017 Apr 27. pii: S1278-3218(17)30057.
    Abstract    

    Abstract available

  46. ALDELAIJAN S, Wadi-Ramahi S, Nobah A, Moftah B, et al
    Commissioning of applicator-guided stereotactic body radiation therapy boost with high-dose-rate brachytherapy for advanced cervical cancer using radiochromic film dosimetry.
    Brachytherapy. 2017 Apr 27. pii: S1538-4721(17)30058.
    Abstract    

    Abstract available

  47. CHEN W, He W, Cai H, Hu B, et al
    A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer.
    Oncotarget. 2017 Apr 11. doi: 10.18632/oncotarget.17034.
    Abstract    

    Abstract available

  48. KUE J, Hanegan H, Tan A
    Perceptions of Cervical Cancer Screening, Screening Behavior, and Post-Migration Living Difficulties Among Bhutanese-Nepali Refugee Women in the United States.
    J Community Health. 2017 Apr 28. doi: 10.1007/s10900-017-0355.
    Abstract    

    Abstract available

  49. XU X, McDermott SW, Mann JR, Hardin JW, et al
    A longitudinal assessment of adherence to breast and cervical cancer screening recommendations among women with and without intellectual disability.
    Prev Med. 2017 Apr 25. pii: S0091-7435(17)30154.
    Abstract    

    Abstract available

  50. ST-AMANT P, Foster W, Froment MA, Aubin S, et al
    Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography.
    Brachytherapy. 2017 Apr 25. pii: S1538-4721(17)30055.
    Abstract    

    Abstract available

  51. SMITH L, van Niekerk D, Coldman A, Krajden M, et al
    Independent Scientists Provide Guidance for the Future of Cervical Cancer Screening.
    J Obstet Gynaecol Can. 2017;39:326-327.
    Abstract    



  52. MANAGIT C, Sakurai H, Saiki I
    Ethanolic extract of Thevetia peruviana flowers enhances TNF-alpha and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathways.
    Oncol Lett. 2017;13:2791-2798.
    Abstract    

    Abstract available

  53. XU Z, Zhou Y, Shi F, Cao Y, et al
    Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Oncol Lett. 2017;13:2784-2790.
    Abstract    

    Abstract available

  54. RONG C, Feng Y, Ye Z
    Notch is a critical regulator in cervical cancer by regulating Numb splicing.
    Oncol Lett. 2017;13:2465-2470.
    Abstract    

    Abstract available

  55. CONG L, Zhang F, Shang H
    Notch1 targeted regulation of mir-224/LRIG2 signaling for the proliferation and apoptosis of cervical cancer cells.
    Oncol Lett. 2017;13:2304-2308.
    Abstract    

    Abstract available

  56. GU J, Hao C, Yan X, Xuan S, et al
    Applied analysis of ultrasound-guided ilioinguinal and iliohypogastric nerve blocks in the radical surgery of aged cervical cancer.
    Oncol Lett. 2017;13:1637-1640.
    Abstract    

    Abstract available

  57. CHEN P, Jiao L, Wang DB
    Squamous cell carcinoma antigen expression in tumor cells is associated with the chemosensitivity and survival of patients with cervical cancer receiving docetaxel-carboplatin-based neoadjuvant chemotherapy.
    Oncol Lett. 2017;13:1235-1241.
    Abstract    

    Abstract available

  58. AHMAD A, Raish M, Shahid M, Batra S, et al
    The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer.
    Cancer Biomark. 2017 Apr 14. doi: 10.3233/CBM-160060.
    Abstract    

    Abstract available

  59. RODRIGUEZ-FERIA P, Hernandez-Florez LJ, Rodriguez-Feria D
    Knowledge, attitudes and practices of prevention for cervical cancer and breast cancer among medical students.
    Rev Salud Publica (Bogota). 2016;18:354-366.
    Abstract    

    Abstract available

  60. VAN LEEUWEN CM, Oei AL, Chin KWTK, Crezee J, et al
    A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer.
    Radiat Oncol. 2017;12:75.
    Abstract    

    Abstract available

  61. GEORGESCU MT, Anghel R
    Variation in uterus position prior to brachytherapy of the cervix: A case report.
    J Med Life. 2017;10:90-93.
    Abstract    

    Abstract available

  62. TYSZKA-CZOCHARA M, Konieczny P, Majka M
    Caffeic Acid Expands Anti-Tumor Effect of Metformin in Human Metastatic Cervical Carcinoma HTB-34 Cells: Implications of AMPK Activation and Impairment of Fatty Acids De Novo Biosynthesis.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  63. MERCADO GUTIERREZ MR, Arean Cuns C, Gomez Dorronsoro ML, Paniello Alastruey I, et al
    [Influence of Age in the Prevalence of High-Risk Human Papiloma Virus in Women with Pre-Neoplasic Cervical Lesions in Navarra, Spain].
    Rev Esp Salud Publica. 2017;91.
    Abstract    

    Abstract available

  64. SHYU RY, Wang CH, Wu CC, Chen ML, et al
    Tazarotene-Induced Gene 1 Enhanced Cervical Cell Autophagy through Transmembrane Protein 192.
    Mol Cells. 2016;39:877-887.
    Abstract    

    Abstract available

  65. MOHYELDIN MM, Akl MR, Siddique AB, Hassan HM, et al
    The marine-derived pachycladin diterpenoids as novel inhibitors of wild-type and mutant EGFR.
    Biochem Pharmacol. 2017;126:51-68.
    Abstract    

    Abstract available

  66. RASK M, Oscarsson M, Lindell G, Swahnberg K, et al
    Women with abnormal Pap smear result: a qualitative study of Swedish healthcare professionals' experiences.
    Eur J Cancer Care (Engl). 2016;25:980-991.
    Abstract    

    Abstract available

  67. SHEN-GUNTHER J, Wang CM, Poage GM, Lin CL, et al
    Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Clin Epigenetics. 2016;8:96.
    Abstract    

    Abstract available

  68. CALMON MF, Sichero L, Boccardo E, Villa LL, et al
    HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines.
    Virology. 2016;496:35-41.
    Abstract    

    Abstract available

  69. CHEN H, Zhang W, Cheng X, Guo L, et al
    beta2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells.
    Cancer Sci. 2017 May 12. doi: 10.1111/cas.13275.
    Abstract    

    Abstract available

  70. LIU Y, Murray-Stewart T, Casero RA Jr, Kagiampakis I, et al
    Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
    Int J Oncol. 2017 May 2. doi: 10.3892/ijo.2017.3979.
    Abstract    

    Abstract available

  71. SCHREVEL M, Osse EM, Prins FA, Trimbos JBMZ, et al
    Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
    Int J Oncol. 2017 May 3. doi: 10.3892/ijo.2017.3980.
    Abstract    

    Abstract available

  72. ZHANG T, Hu Y, Wang T, Cai P, et al
    Dihydroartemisinin inhibits the viability of cervical cancer cells by upregulating caveolin 1 and mitochondrial carrier homolog 2: Involvement of p53 activation and NAD(P)H:quinone oxidoreductase 1 downregulation.
    Int J Mol Med. 2017 May 9. doi: 10.3892/ijmm.2017.2980.
    Abstract    

    Abstract available

  73. PIAO J, You K, Guo Y, Zhang Y, et al
    Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
    Int J Oncol. 2017 Apr 27. doi: 10.3892/ijo.2017.3978.
    Abstract    

    Abstract available

  74. JIN Y, Qiu S, Shao N, Zheng J, et al
    Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
    Mamm Genome. 2017 May 11. doi: 10.1007/s00335-017-9691.
    Abstract    

    Abstract available

  75. AMINI E, Nabiuni M, Baharara J, Parivar K, et al
    In-vitro Pro Apoptotic Effect of Crude Saponin from Ophiocoma erinaceus against Cervical Cancer.
    Iran J Pharm Res. 2017;16:266-276.
    Abstract    

    Abstract available

  76. FENG Y, Zou W, Hu C, Li G, et al
    Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
    Arch Biochem Biophys. 2017 May 8. pii: S0003-9861(16)30512.
    Abstract    

    Abstract available

  77. SINGH R, Chopra S, Engineer R, Paul S, et al
    Dose-volume correlation of cumulative vaginal doses and late toxicity after adjuvant external radiation and brachytherapy for cervical cancer.
    Brachytherapy. 2017 May 8. pii: S1538-4721(17)30057.
    Abstract    

    Abstract available

  78. KELLY PJ, Ramaswamy M
    Closing the cervical cancer disparity gap.
    Public Health Nurs. 2017;34:195-196.
    Abstract    



  79. MASON SA, O'Shea TP, White IM, Lalondrelle S, et al
    Towards ultrasound-guided adaptive radiotherapy for cervical cancer: evaluation of Elekta's semi-automated uterine segmentation method on 3D ultrasound images.
    Med Phys. 2017 May 10. doi: 10.1002/mp.12325.
    Abstract    

    Abstract available

  80. SUNG UK L, Young Ae K, Young-Ho Y, Yeon-Joo K, et al
    General health status of long-term cervical cancer survivors after radiotherapy.
    Strahlenther Onkol. 2017 May 10. doi: 10.1007/s00066-017-1143.
    Abstract    

    Abstract available

  81. PAREDES P, Vidal-Sicart S, Campos F, Tapias A, et al
    Role of ICG-99mTc-nanocolloid for sentinel lymph node detection in cervical cancer: a pilot study.
    Eur J Nucl Med Mol Imaging. 2017 May 10. doi: 10.1007/s00259-017-3706.
    Abstract    

    Abstract available

  82. ZHAO Y, Lai Y, Ge H, Guo Y, et al
    Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells.
    Cell Death Dis. 2017;8:e2773.
    Abstract    

    Abstract available

  83. HU R, Zheng M, Wu J, Li C, et al
    Core-Shell Magnetic Gold Nanoparticles for Magnetic Field-Enhanced Radio-Photothermal Therapy in Cervical Cancer.
    Nanomaterials (Basel). 2017;7.
    Abstract    

    Abstract available

  84. HE G, Yang L, Qian X, Li J, et al
    A coumarin-based fluorescence resonance energy transfer probe targeting matrix metalloproteinase-2 for the detection of cervical cancer.
    Int J Mol Med. 2017;39:1571-1579.
    Abstract    

    Abstract available

  85. CHENG YM, Shen CJ, Chang CC, Chou CY, et al
    Inducement of apoptosis by cucurbitacin E, a tetracyclic triterpenes, through death receptor 5 in human cervical cancer cell lines.
    Cell Death Discov. 2017;3:17014.
    Abstract    

    Abstract available

  86. WANG JG, Cox PG
    A Woman in Her 30s With a History of Cervical Cancer Presents With Shortness of Breath and Pleuritic Chest Pain.
    Chest. 2017;151:e115-e118.
    Abstract    

    Abstract available

  87. CHANG L, Ma D, Li O, Wang X, et al
    Expressions and Functions of Kruppel Like Factor 5 and Tumor Necrosis Factor Receptor Superfamily Member 11a in Cervical Cancer Tissues and Cells.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017;39:196-205.
    Abstract    

    Abstract available

  88. ARAUJO M, Franck JE, Cadot E, Gautier A, et al
    Contextual determinants of participation in cervical cancer screening in France, 2010.
    Cancer Epidemiol. 2017;48:117-123.
    Abstract    

    Abstract available

  89. TINGI E, Crosbie EJ, Owens G
    Optimising fertility outcomes for women with early-stage cervical cancer: when less is more.
    BJOG. 2017 May 8. doi: 10.1111/1471-0528.14725.
    Abstract    

    Abstract available

  90. ADIBE MO, Aluh DO
    Awareness, Knowledge and Attitudes Towards Cervical Cancer Amongst HIV-Positive Women Receiving Care in a Tertiary Hospital in Nigeria.
    J Cancer Educ. 2017 May 5. doi: 10.1007/s13187-017-1229.
    Abstract    

    Abstract available

  91. LUVERO D, Plotti F, Lopez S, Scaletta G, et al
    Antiangiogenics and immunotherapies in cervical cancer: an update and future's view.
    Med Oncol. 2017;34:115.
    Abstract    

    Abstract available

  92. BACALBASA N, Balescu I, Marcu M, Oprescu DN, et al
    Solitary Splenic Metastasis After Surgically-treated Cervical Cancer - A Case Report and Literature Review.
    Anticancer Res. 2017;37:2615-2618.
    Abstract    

    Abstract available

  93. MAYER S, Gabriel B, Erbes T, Timme-Bronsert S, et al
    Cyr61 Expression Pattern and Association with Clinicopathological Factors in Patients with Cervical Cancer.
    Anticancer Res. 2017;37:2451-2456.
    Abstract    

    Abstract available

  94. BAHRAMI A, Hasanzadeh M, Hassanian SM, ShahidSales S, et al
    The potential value of the PI3K/Akt/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy.
    J Cell Biochem. 2017 May 5. doi: 10.1002/jcb.26118.
    Abstract    

    Abstract available

  95. WALKER S, Hamilton W
    Risk of cervical cancer in symptomatic women aged >/=40 in primary care: A case-control study using electronic records.
    Eur J Cancer Care (Engl). 2017 May 4. doi: 10.1111/ecc.12706.
    Abstract    

    Abstract available

  96. WHITE MC, Shoemaker ML, Benard VB
    Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    Am J Prev Med. 2017 Apr 26. pii: S0749-3797(17)30175.
    Abstract    

    Abstract available

  97. LIU C, Lu J, Tian H, Du W, et al
    Increased expression of PDL1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity.
    Mol Med Rep. 2017;15:1063-1070.
    Abstract    

    Abstract available

  98. HEARD I, Tondeur L, Arowas L, Demazoin M, et al
    Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France.
    J Infect Dis. 2016 Dec 23. pii: jiw639. doi: 10.1093.
    Abstract    

    Abstract available

  99. ARBYN M, Xu L, Verdoodt F, Cuzick J, et al
    Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2017;166:118-127.
    Abstract    

    Abstract available

  100. FADIEL A, Choi SD, Park B, Kim TH, et al
    Expression of Ezrin and Estrogen Receptors During Cervical Carcinogenesis.
    Reprod Sci. 2017;24:706-712.
    Abstract    

    Abstract available

  101. WANG Y, Cui T, Du L, Xu X, et al
    The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma.
    J Clin Lab Anal. 2017;31.
    Abstract    

    Abstract available

  102. STRICKLAND SW, Vande Pol S
    The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
    J Virol. 2016;90:5611-21.
    Abstract    

    Abstract available

  103. NIYAZI M, Sui S, Zhu K, Wang L, et al
    Correlation between Methylation of Human Papillomavirus-16 L1 Gene and Cervical Carcinoma in Uyghur Women.
    Gynecol Obstet Invest. 2017;82:22-29.
    Abstract    

    Abstract available

  104. BRONOWICKA-KLYS DE, Roszak A, Pawlik P, Sajdak S, et al
    Transcript levels of ten-eleven translocation type 1-3 in cervical cancer and non-cancerous cervical tissues.
    Oncol Lett. 2017;13:3921-3927.
    Abstract    

    Abstract available

  105. TONG R, Yang Q, Wang C, Bi F, et al
    OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.
    Oncol Lett. 2017;13:2929-2936.
    Abstract    

    Abstract available

  106. KABEKKODU SP, Chakrabarty S, Ghosh S, Brand A, et al
    Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
    Public Health Genomics. 2017 May 19. doi: 10.1159/000475804.
    Abstract    

    Abstract available

  107. CUI X, Jing X, Wu X
    The prognostic value of long non coding RNAs in cervical cancer: A meta-analysis.
    Oncotarget. 2017 May 4. doi: 10.18632/oncotarget.17620.
    Abstract    

    Abstract available

  108. LIN M, Xue X, Liang SZ, Li YX, et al
    MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.
    Oncotarget. 2017 Apr 29. doi: 10.18632/oncotarget.17516.
    Abstract    

    Abstract available

  109. LI Y, Cui N, Zheng PS, Yang WT, et al
    BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
    Oncotarget. 2017 Apr 27. doi: 10.18632/oncotarget.17493.
    Abstract    

    Abstract available

  110. DE ALMEIDA LM, Martins LFL, Pontes VB, Correa FM, et al
    Human Papillomavirus Genotype Distribution among Cervical Cancer Patients prior to Brazilian National HPV Immunization Program.
    J Environ Public Health. 2017;2017:1645074.
    Abstract    

    Abstract available

  111. PARK CW, Song YS, Lee HP, Hong JT, et al
    (E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol induces apoptosis in HeLa cervical cancer cells via the extrinsic apoptotic pathway.
    J Microbiol Biotechnol. 2017 May 17. doi: 10.4014/jmb.1703.03060.
    Abstract    

    Abstract available

  112. PATNI N, Burela N, Pasricha R, Goyal J, et al
    Assessment of three-dimensional setup errors in image-guided pelvic radiotherapy for uterine and cervical cancer using kilovoltage cone-beam computed tomography and its effect on planning target volume margins.
    J Cancer Res Ther. 2017;13:131-136.
    Abstract    

    Abstract available

  113. UENO Y, Lisbona R, Tamada T, Alaref A, et al
    Comparison of FDG PET Metabolic Tumour Volume versus ADC Histogram: Prognostic Value of Tumour Treatment Response and Survival in Patients with Locally Advanced Uterine Cervical Cancer.
    Br J Radiol. 2017 May 16:20170035. doi: 10.1259/bjr.20170035.
    Abstract    

    Abstract available

  114. PELLEGRINO A, Damiani GR, Fachechi G, Pirovano C, et al
    Cost analysis of minimally invasive radical hysterectomy for cervical cancer performed by a single surgeon in an Italian center: an update in gynecologic oncological field.
    Updates Surg. 2017 May 15. doi: 10.1007/s13304-017-0462.
    Abstract    

    Abstract available

  115. XU F, Zhang J, Hu G, Liu L, et al
    Hypoxia and TGF-beta1 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation.
    Cancer Cell Int. 2017;17:54.
    Abstract    

    Abstract available

  116. VAN MINH H, My NTT, Jit M
    Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.
    BMC Health Serv Res. 2017;17:353.
    Abstract    

    Abstract available

  117. WATSON M, Benard V, King J, Crawford A, et al
    National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
    Prev Med. 2017 May 11. pii: S0091-7435(17)30168.
    Abstract    

    Abstract available

  118. ARORA A, Rastogi A, Neyaz A, Husain N, et al
    Clear cell adenocarcinoma of cervix in 1-year-old girl without in utero exposure to diethylstilbestrol: an uncommon tumour at an uncommon age and site.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  119. SMITH RA, Andrews KS, Brooks D, Fedewa SA, et al
    Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.
    CA Cancer J Clin. 2017;67:100-121.
    Abstract    

    Abstract available

  120. SZALMAS A, Tomaic V, Basukala O, Massimi P, et al
    The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.
    J Virol. 2017;91.
    Abstract    

    Abstract available

  121. LOPALCO PL
    Spotlight on the 9-valent HPV vaccine.
    Drug Des Devel Ther. 2016;11:35-44.
    Abstract    

    Abstract available

  122. WHEELER CM, Skinner SR, Del Rosario-Raymundo MR, Garland SM, et al
    Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
    Lancet Infect Dis. 2016 Jun 28. pii: S1473-3099(16)30120.
    Abstract    

    Abstract available


  123. Barriers to Cervical Cancer Screening in Geneva (DEPIST Study): Erratum.
    J Low Genit Tract Dis. 2017;21:162.
    Abstract    



  124. KHATTAK F, Haseeb M, Fazal S, Bhatti AI, et al
    Mathematical Modeling of E6-p53 interactions in Cervical Cancer
    Asian Pac J Cancer Prev. 2017;18:1057-1061.
    Abstract    

    Abstract available

  125. REMA P, Mathew AP, Suchetha S, Ahmed I, et al
    Salvage Surgery for Cervical Cancer Recurrences.
    Indian J Surg Oncol. 2017;8:146-149.
    Abstract    

    Abstract available

  126. YIN CM, Yao YF, Yan ZL, Yang HY, et al
    [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:320-326.
    Abstract    

    Abstract available

  127. SALEM MR, Amin TT, Alhulaybi AA, Althafar AS, et al
    Perceived Risk of Cervical Cancer and Barriers to Screening among Secondary School Female Teachers in Al Hassa, Saudi Arabia
    Asian Pac J Cancer Prev. 2017;18:969-979.
    Abstract    

    Abstract available

  128. PAN X, Jiang B, Liu J, Ding J, et al
    STC1 promotes cell apoptosis via NF-kappaB phospho-P65 Ser536 in cervical cancer cells.
    Oncotarget. 2017 May 5. doi: 10.18632/oncotarget.17641.
    Abstract    

    Abstract available

  129. HE SH, Liu HG, Zhou YF, Yue QF, et al
    Liquiritin (LT) exhibits suppressive effects against the growth of human cervical cancer cells through activating Caspase-3 in vitro and xenograft mice in vivo.
    Biomed Pharmacother. 2017;92:215-228.
    Abstract    

    Abstract available

  130. JIN X, Chen X, Hu Y, Ying F, et al
    LncRNA-TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR-143-5p.
    Cancer Med. 2017 May 23. doi: 10.1002/cam4.1084.
    Abstract    

    Abstract available

  131. LIAO S, Xiao S, Chen H, Zhang M, et al
    CD38 enhances the proliferation and inhibits the apoptosis of cervical cancer cells by affecting the mitochondria functions.
    Mol Carcinog. 2017 May 23. doi: 10.1002/mc.22677.
    Abstract    

    Abstract available

  132. BAHRAMI A, Hasanzadeh M, Shahidsales S, Farazestanian M, et al
    Genetic susceptibility in cervical cancer: from bench to bedside.
    J Cell Physiol. 2017 May 19. doi: 10.1002/jcp.26019.
    Abstract    

    Abstract available

  133. CLARK AK, Sarcon AK, Fung MAFA, Konia T, et al
    Malignancy-associated Sweet syndrome: acute febrile neutrophilic dermatosis associated with recurrence of metastatic cervical cancer.
    Dermatol Online J. 2017;23.
    Abstract    

    Abstract available

  134. DE SANJOSE S, Temin S, Garland S, Eckert LO, et al
    Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline Summary.
    J Oncol Pract. 2017 May 25:JOP2017021949. doi: 10.1200/JOP.2017.021949.
    Abstract    



  135. MATSUO K, Shimada M, Mikami M
    Ovarian conservation for young women with clinical stage IB-IIB cervical cancer in Japan.
    J Gynecol Oncol. 2017;28:e60.
    Abstract    



  136. HANPRASERTPONG J, Jiamset I, Geater A, Leetanaporn K, et al
    Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
    J Gynecol Oncol. 2017;28:e42.
    Abstract    

    Abstract available

  137. ZHAO XL, Hu SY, Zhang Q, Dong L, et al
    High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    J Gynecol Oncol. 2017;28:e30.
    Abstract    

    Abstract available

  138. YILDIRIM M, Muller von der Grun J, Winkelmann R, Fokas E, et al
    Erratum to: Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters.
    Strahlenther Onkol. 2017 May 24. doi: 10.1007/s00066-017-1155.
    Abstract    



  139. SIMSEK E, Imir N, Aydemir EA, Gokturk RS, et al
    Caspase-mediated Apoptotic Effects of Ebenus boissieri Barbey Extracts on Human Cervical Cancer Cell Line HeLa.
    Pharmacogn Mag. 2017;13:254-259.
    Abstract    

    Abstract available

  140. LEE CH, Ying TH, Chiou HL, Hsieh SC, et al
    Alpha-mangostin induces apoptosis through activation of reactive oxygen species and ASK1/p38 signaling pathway in cervical cancer cells.
    Oncotarget. 2017 May 7. doi: 10.18632/oncotarget.17659.
    Abstract    

    Abstract available

  141. YOON WS, Yang DS, Lee JA, Lee NK, et al
    Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors.
    Biomed Res Int. 2017;2017:2917925.
    Abstract    

    Abstract available

  142. DEGREGORIO G, Manga S, Kiyang E, Manjuh F, et al
    Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
    Oncologist. 2017 May 23. pii: theoncologist.2016-0383.
    Abstract    

    Abstract available

  143. HAN Y, Wu LY, Li N, Li XG, et al
    [Clinical Analysis of Surgery for Recurrent Cervical Cancer: A Review of 45 Cases].
    Zhonghua Zhong Liu Za Zhi. 2017;39:369-373.
    Abstract    

    Abstract available

  144. WEI H, Wen-Ming C, Jun-Bo J
    Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer.
    J Int Med Res. 2017 Jan 1:300060517709614. doi: 10.1177/0300060517709614.
    Abstract    

    Abstract available

  145. WU Q, Zheng D, Shi L, Liu M, et al
    Differentiating metastatic from nonmetastatic lymph nodes in cervical cancer patients using monoexponential, biexponential, and stretched exponential diffusion-weighted MR imaging.
    Eur Radiol. 2017 May 22. doi: 10.1007/s00330-017-4873.
    Abstract    

    Abstract available

  146. HARKENRIDER MM, Shea SM, Wood AM, Chinsky B, et al
    How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer.
    J Contemp Brachytherapy. 2017;9:177-186.
    Abstract    

    Abstract available

  147. TAMAKI T, Miyaura K, Murakami T, Kumazaki Y, et al
    The use of trans-applicator intracavitary ultrasonography in brachytherapy for cervical cancer: phantom study of a novel approach to 3D image-guided brachytherapy.
    J Contemp Brachytherapy. 2017;9:151-157.
    Abstract    

    Abstract available

  148. MAHANTSHETTY U, Shetty S, Majumder D, Adurkar P, et al
    Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study.
    J Contemp Brachytherapy. 2017;9:112-117.
    Abstract    

    Abstract available

  149. URRUTIA MT, Gajardo M, Padilla O
    Development and testing of the questionnaire CEC-61: Knowledge about cervical cancer in Chilean adolescents.
    Women Health. 2017 May 22. doi: 10.1080/03630242.2017.1333073.
    Abstract    

    Abstract available

  150. WU E, Tiggelaar SM, Jiang T, Zhao H, et al
    Cervical Cancer Prevention-Related Knowledge and Attitudes among Female Undergraduate Students from Different Ethnic Groups within China, a Survey-Based Study.
    Women Health. 2017 May 22. doi: 10.1080/03630242.2017.1333076.
    Abstract    

    Abstract available

  151. UMESH M, Kumar DP, Chadha P, Choudary R, et al
    Transabdominal Ultrasonography-Defined Optimal and Definitive Bladder-Filling Protocol With Time Trends During Pelvic Radiation for Cervical Cancer.
    Technol Cancer Res Treat. 2017 Jan 1:1533034617709596.
    Abstract    

    Abstract available

  152. BURGER EA, Kim JJ, Sy S, Castle PE, et al
    Age of acquiring causal human papillomavirus (HPV) infections: Leveraging simulation models to explore the natural history of HPV-induced cervical cancer.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    Abstract    

    Abstract available


  153. Human papillomavirus vaccines: WHO position paper, May 2017.
    Wkly Epidemiol Rec. 2017;92:241-68.
    Abstract    



  154. WANG Z, Wang J, Fan J, Zhao W, et al
    Risk factors for cervical intraepithelial neoplasia and cervical cancer in Chinese women: large study in Jiexiu, Shanxi Province, China.
    J Cancer. 2017;8:924-932.
    Abstract    

    Abstract available

  155. XIAO J, Zhou J, Fu M, Liang L, et al
    Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial.
    Oncol Lett. 2017;13:3676-3680.
    Abstract    

    Abstract available

  156. ZHANG P, Kong F, Deng X, Yu Y, et al
    MicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1.
    Oncol Lett. 2017;13:2949-2956.
    Abstract    

    Abstract available

  157. TOTA JE, Struyf F, Merikukka M, Gonzalez P, et al
    Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.
    J Natl Cancer Inst. 2017;109.
    Abstract    

    Abstract available

  158. KO K, Kwon MJ, Lee EH, Woo HY, et al
    Comparison of GeneFinder human papillomavirus (HPV) Liquid Beads Microarray PCR Kit and Hybrid Capture 2 Assay for Detection of HPV Infection.
    J Clin Lab Anal. 2017;31.
    Abstract    

    Abstract available

  159. MATTHIJSSE SM, Hontelez JA, Naber SK, Rozemeijer K, et al
    Public health benefits of routine human papillomavirus vaccination for adults in the Netherlands: a mathematical modeling study.
    J Infect Dis. 2016.
    Abstract    

    Abstract available

  160. TAN G, Hawkes D
    Addressing Confusion about the Risks and Benefits of Co-Testing versus Human Papillomavirus Testing for Cervical Cancer Screening.
    Acta Cytol. 2017 May 5. doi: 10.1159/000472244.
    Abstract    



  161. MILLS AM, Dirks DC, Poulter MD, Mills SE, et al
    HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Am J Surg Pathol. 2017;41:607-615.
    Abstract    

    Abstract available

  162. WADA T, Ohishi Y, Kaku T, Aman M, et al
    Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Am J Surg Pathol. 2017;41:696-705.
    Abstract    

    Abstract available

  163. DICKIE BR, Rose CJ, Kershaw LE, Withey SB, et al
    The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability.
    Br J Cancer. 2017 Apr 27. doi: 10.1038/bjc.2017.
    Abstract    

    Abstract available

  164. LUTTMER R, De Strooper LM, Dijkstra MG, Berkhof J, et al
    FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
    Br J Cancer. 2016 Jul 14. doi: 10.1038/bjc.2016.
    Abstract    

    Abstract available

  165. SOGAARD M, Farkas DK, Ording AG, Sorensen HT, et al
    Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer.
    Br J Cancer. 2016 Jun 2. doi: 10.1038/bjc.2016.
    Abstract    

    Abstract available

  166. SMALL W JR, Bacon MA, Bajaj A, Chuang LT, et al
    Cervical cancer: A global health crisis.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30667.
    Abstract    

    Abstract available

  167. KOROUKIAN SM, Bakaki PM, Htoo PT, Han X, et al
    The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30720.
    Abstract    

    Abstract available

  168. PAGANO A, Dennis K
    Cribriform adenocarcinoma of the minor salivary gland arising in the tonsil with metastasis to a cervical lymph node: A case report with description of fine needle aspiration cytology.
    Diagn Cytopathol. 2017;45:468-471.
    Abstract    

    Abstract available

  169. MARLOW LAV, Chorley AJ, Haddrell J, Ferrer R, et al
    Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women.
    Eur J Cancer. 2017;80:30-38.
    Abstract    

    Abstract available

  170. DAI Y, Tong R, Guo H, Yu T, et al
    Association of CXCR4, CCR7, VEGF-C and VEGF-D expression with lymph node metastasis in patients with cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;214:178-183.
    Abstract    

    Abstract available

  171. LEE J, Lin JB, Chang CL, Jan YT, et al
    Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
    Gynecol Oncol. 2017 Apr 27. pii: S0090-8258(17)30797.
    Abstract    

    Abstract available

  172. RENDON GJ, Echeverri L, Echeverri F, Sanz-Lomana CM, et al
    Outpatient laparoscopic nerve-sparing radical hysterectomy: A feasibility study and analysis of perioperative outcomes.
    Gynecol Oncol. 2016 Aug 9. pii: S0090-8258(16)31256.
    Abstract    

    Abstract available

  173. MANLEY KM, Wills AK, Morris GC, Hogg JL, et al
    The impact of HPV cervical screening on negative large loop excision of the transformation zone (LLETZ): A comparative cohort study.
    Gynecol Oncol. 2016 Mar 28. pii: S0090-8258(16)30088.
    Abstract    

    Abstract available

  174. DE STROOPER LM, Verhoef VM, Berkhof J, Hesselink AT, et al
    Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.
    Gynecol Oncol. 2016 Feb 24. pii: S0090-8258(16)30036.
    Abstract    

    Abstract available

  175. WOLF B, Ganzer R, Stolzenburg JU, Hentschel B, et al
    Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields.
    Gynecol Oncol. 2017 May 16. pii: S0090-8258(17)30845.
    Abstract    

    Abstract available

  176. SWAILES AL, Gockley A, Phaeton R, Kesterson JP, et al
    The Wertheim hysterectomy: Development, modifications, and impact in the present day.
    Gynecol Oncol. 2017 Jan 13. pii: S0090-8258(17)30049.
    Abstract    

    Abstract available

  177. VERLOOP J, van Leeuwen FE, Helmerhorst TJ, de Kok IM, et al
    Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.
    Gynecol Oncol. 2017;144:305-311.
    Abstract    

    Abstract available

  178. KUJI S, Watanabe R, Sato Y, Iwata T, et al
    A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
    Gynecol Oncol. 2016 Nov 28. pii: S0090-8258(16)31576.
    Abstract    

    Abstract available

  179. SULLIVAN SA, Clark LH, Staley AS, Tran AQ, et al
    Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complications.
    Gynecol Oncol. 2016 Nov 25. pii: S0090-8258(16)31606.
    Abstract    

    Abstract available

  180. ROHNER E, Sengayi M, Goeieman B, Michelow P, et al
    Cervical Cancer Risk and Impact of Pap-based Screening in HIV-positive Women on Antiretroviral Therapy in Johannesburg, South Africa.
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30749.
    Abstract    

    Abstract available

  181. SCHIFFMAN M, Yu K, Zuna R, Terence Dunn S, et al
    Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have >/=CIN2.
    Int J Cancer. 2016 Oct 1. doi: 10.1002/ijc.30456.
    Abstract    

    Abstract available

  182. POLMAN NJ, Uijterwaal MH, Witte BI, Berkhof J, et al
    Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
    Int J Cancer. 2017;140:423-430.
    Abstract    

    Abstract available

  183. CHEN W, Molijn A, Enqi W, Zhang X, et al
    The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.
    Int J Cancer. 2016;139:2687-2697.
    Abstract    

    Abstract available

  184. SIMMS KT, Smith MA, Lew JB, Kitchener HC, et al
    Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
    Int J Cancer. 2016 Aug 19. doi: 10.1002/ijc.30392.
    Abstract    

    Abstract available

  185. LAM JU, Rebolj M, Moller Ejegod D, Pedersen H, et al
    Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
    Int J Cancer. 2017;140:2212-2219.
    Abstract    

    Abstract available

  186. NICOLAS-PARRAGA S, Alemany L, de Sanjose S, Bosch FX, et al
    Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma.
    Int J Cancer. 2017;140:2092-2100.
    Abstract    

    Abstract available

  187. SCHIFFMAN M, Hyun N, Raine-Bennett TR, Katki H, et al
    A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30375.
    Abstract    

    Abstract available

  188. CASTANON A, Landy R, Sasieni PD
    Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
    Int J Cancer. 2016;139:1040-5.
    Abstract    

    Abstract available

  189. CAMPBELL C, Kafwafwa S, Brown H, Walker G, et al
    Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.
    Int J Cancer. 2016;139:908-15.
    Abstract    

    Abstract available

  190. EBISCH RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, et al
    The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
    Int J Cancer. 2016 Mar 17. doi: 10.1002/ijc.30090.
    Abstract    

    Abstract available

  191. BROTHERTON JM, Jit M, Gravitt PE, Brisson M, et al
    Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30063.
    Abstract    

    Abstract available

  192. MATSUO K, Shimada M, Aoki Y, Sakamoto M, et al
    Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
    Int J Cancer. 2017 May 19. doi: 10.1002/ijc.30793.
    Abstract    

    Abstract available

  193. KOCSIS A, Takacs T, Jeney C, Schaff Z, et al
    Performance of a New HPV and Biomarker Assay in Management of hrHPV Positive Women: Subanalysis of the Ongoing Multicenter TRACE Clinical Trial (n>6,000) to Evaluate POU4F3 as a Potential Biomarker of Cervical Precancer and Cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30534.
    Abstract    

    Abstract available

  194. MIYAMOTO S, Hasegawa J, Morioka M, Hirota Y, et al
    The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2.
    Int J Gynaecol Obstet. 2016;134:45-8.
    Abstract    

    Abstract available

  195. NEGULESCU RA, Catarino R, De Vuyst H, Undurraga-Malinverno M, et al
    Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers.
    Int J Gynaecol Obstet. 2016;134:107-13.
    Abstract    

    Abstract available

  196. BOONLIKIT S
    Performance of the abbreviated Reid colposcopic index in prediction of high-grade lesions.
    Int J Gynaecol Obstet. 2016;134:41-4.
    Abstract    

    Abstract available

  197. NAUD PS, Muwonge R, Passos EP, Magno V, et al
    Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil.
    Int J Gynaecol Obstet. 2016;133:351-4.
    Abstract    

    Abstract available

  198. FIGUEROA-DOWNING D, Baggio ML, Baker ML, Dias De Oliveira Chiang E, et al
    Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in Sao Paulo, Brazil.
    Int J Gynaecol Obstet. 2017;136:33-39.
    Abstract    

    Abstract available

  199. ZHANG G, Lang J, Shen K, Zhu L, et al
    High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years.
    Int J Gynaecol Obstet. 2017;136:47-52.
    Abstract    

    Abstract available

  200. FAJARDO-RAMIREZ OR, Barboza-Cerda MC, Ortiz-Lopez R, Rojas-Martinez A, et al
    Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.
    Int J Gynaecol Obstet. 2017;136:40-46.
    Abstract    

    Abstract available

  201. MARIANI L, Igidbashian S, Sandri MT, Vici P, et al
    The clinical implementation of primary HPV screening.
    Int J Gynaecol Obstet. 2016 Nov 21. doi: 10.1002/ijgo.12065.
    Abstract    

    Abstract available

  202. MARIANI L, Preti M, Cristoforoni P, Stigliano CM, et al
    Overview of the benefits and potential issues of the nonavalent HPV vaccine.
    Int J Gynaecol Obstet. 2016 Dec 7. doi: 10.1002/ijgo.12075.
    Abstract    

    Abstract available

  203. ROSEN VM, Guerra I, McCormack M, Nogueira-Rodrigues A, et al
    Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.
    Int J Gynecol Cancer. 2017 Apr 26. doi: 10.1097/IGC.0000000000001000.
    Abstract    

    Abstract available

  204. WEN Q, Liu Y, Lyu H, Xu X, et al
    Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 2. doi: 10.1097/IGC.0000000000001028.
    Abstract    

    Abstract available

  205. DERKS M, Groenman FA, van Lonkhuijzen LRCW, Schut PC, et al
    Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000974.
    Abstract    

    Abstract available

  206. BAKKER RM, Pieterse QD, van Lonkhuijzen LRCW, Trimbos BJBMZ, et al
    A Controlled Study on Vaginal Blood Flow During Sexual Arousal Among Early-Stage Cervical Cancer Survivors Treated With Conventional Radical or Nerve-Sparing Surgery With or Without Radiotherapy.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000986.
    Abstract    

    Abstract available

  207. PLANTE M, Renaud MC, Sebastianelli A, Gregoire J, et al
    Simple Vaginal Trachelectomy: A Valuable Fertility-Preserving Option in Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000989.
    Abstract    

    Abstract available

  208. ZHENG RR, Huang XW, Liu WY, Lin RR, et al
    Nomogram Predicting Overall Survival in Operable Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000987.
    Abstract    

    Abstract available

  209. TOMAO F, Maruccio M, Preti EP, Boveri S, et al
    Conization in Early Stage Cervical Cancer: Pattern of Recurrence in a 10-Year Single-Institution Experience.
    Int J Gynecol Cancer. 2017 May 8. doi: 10.1097/IGC.0000000000000991.
    Abstract    

    Abstract available

  210. SMELTZER S, Yu X, Schmeler K, Levison J, et al
    Abnormal Vaginal Pap Test After Hysterectomy in Human Immunodeficiency Virus-Infected Women.
    Obstet Gynecol. 2016;127.
    Abstract    

    Abstract available

  211. LIN W, Feng M, Chen G, Zhou Z, et al
    Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
    Oncol Rep. 2017;37:1477-1486.
    Abstract    

    Abstract available

  212. LUAN X, Wang Y
    Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5663.
    Abstract    

    Abstract available

  213. DE BOER P, Jurgenliemk-Schulz IM, Westerveld H, de Leeuw AAC, et al
    Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.
    Radiother Oncol. 2017 Apr 20. pii: S0167-8140(17)30145.
    Abstract    

    Abstract available

  214. DEL CAMPO ER, Rivera S, Martinez-Paredes M, Hupe P, et al
    Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs).
    Radiother Oncol. 2017 May 19. pii: S0167-8140(17)30372.
    Abstract    

    Abstract available

  215. LI N, Noticewala SS, Williamson CW, Shen H, et al
    Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.
    Radiother Oncol. 2017;123:325-330.
    Abstract    

    Abstract available

  216. KIM SW, Chun M, Ryu HS, Chang SJ, et al
    Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.
    BMC Cancer. 2017;17:297.
    Abstract    

    Abstract available

  217. WANG W, Li Y, Liu N, Gao Y, et al
    MiR-23b controls ALDH1A1 expression in cervical cancer stem cells.
    BMC Cancer. 2017;17:292.
    Abstract    

    Abstract available

  218. CHANG C, Hsieh MK, Chang WY, Chiang AJ, et al
    Determining the optimal number and location of cutoff points with application to data of cervical cancer.
    PLoS One. 2017;12:e0176231.
    Abstract    

    Abstract available

  219. WANG L, Shen H, Feng B, Zhu D, et al
    Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions.
    PLoS One. 2017;12:e0175520.
    Abstract    

    Abstract available

  220. CHEN M, Zhang Y, Zheng PS
    Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis.
    PLoS One. 2017;12:e0177171.
    Abstract    

    Abstract available

  221. MCKAY J, Tenet V, Franceschi S, Chabrier A, et al
    Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.
    PLoS One. 2017;12:e0177775.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;